Abstract
This Article will describe the basic tenets of the 2009 PhRMA Code, how the 2009 PhRMA Code has been relied upon by at least one state in crafting its own response to the industry-healthcare professional debate, and it will conclude with a brief overview of pending activity apart from the self-policing guidance of the 2009 PhRMA Code with an outlook on the future of the compliance debate.
Recommended Citation
Howard L. Dorfman, The 2009 Revision to the PhRMA Code on Interactions with Healthcare Professionals: Challenges and Opportunities for the Pharmaceutical Industry in the Age of Compliance, 31 Campbell L. Rev. 361 (2009).